Table 1.

Associations between CSF-1R expression and clinicopathological characteristics in 103 COAD patients.

Variable	Total	CSF-1R expression		P
		Low	High
Age
≥60	39	18 (17.5%)	21 (20.3%)	0.812
<60	64	28 (27.2%)	36 (35.0%)
Gender
Male	55	26 (25.2%)	29 (28.2%)	0.568
Female	48	20 (19.4%)	28 (27.2%)
Tumor recurrence
Yes	28	13 (12.6%)	15 (14.6%)	0.825
No	75	33 (32.0%)	42 (40.8%)
Histological grade
Well	4	2 (1.9%)	2 (1.9%)	0.736
Moderate	84	36 (35.0%)	48 (46.6%)
Poor	15	8 (7.8%)	7 (6.8%)
T stage
T1	2	1 (1.0%)	1 (1.0%)	0.103
T2	8	2 (1.9%)	6 (5.9%)
T3	52	26 (25.2%)	26 (25.2%)
T4	41	17 (16.5%)	24 (23.3%)
N stage
N0	65	28 (27.2%)	37 (35.9%)	0.912
N1	23	11 (10.7%)	12 (11.7)
N2	15	7 (6.8%)	8 (7.7%)
M stage
M0	69	36 (35.0%)	33 (32.0%)	0.029
M1	34	10 (9.7%)	24 (23.3%)
AJCC stage
I	7	1 (1.0%)	6 (5.8%)	0.023
II	40	24 (23.3%)	16 (15.5)
III	22	11 (10.7%)	11 (10.7%))
IV	34	10 (9.7%)	24 (23.3%)
Tumor size
≥6cm	60	29 (28.2%)	31 (30.1%)	0.376
<6cm	43	17 (16.5%)	26 (25.2%)

Bold P < 0.05.